CBD for Epilepsy Needs Evidence, Monitoring, and Better Trial Precision
medical cannabis research: A PubMed indexed review argues that cannabidiol has meaningful antiseizure potential in select refractory epilepsies, but its dosing, interactions, mechanisms, and long term safety still require careful clinical structure. It…
When One Substance Policy Changes Another Substance Use
medical cannabis research: A 95 study systematic review finds tobacco, cannabis, and alcohol policies often spill across substances, but substitution, complementarity, and independence vary by policy type and population. It keeps the evidence readable…
When Tobacco, Cannabis, and Alcohol Policies Spill Over Into Each Other
medical cannabis research: A 95-study systematic review finds that tobacco, cannabis, and alcohol policies often influence use of other substances, but the direction depends on policy type, population, and substance pairing. It keeps the evidence…
When Cannabis, Alcohol, and Tobacco Policies Collide
medical cannabis research: A 95-study systematic review finds that substance policies often spill across cannabis, alcohol, and tobacco use, but the direction depends heavily on policy type, population, and substance pairing. It keeps the evidence…
When Cannabis, Tobacco, and Alcohol Policies Collide
medical cannabis research: A 95-study systematic review finds that policies aimed at one substance often influence use of others, but the direction of change depends heavily on policy type, population, and context. It keeps the evidence readable for…
Cannabis Use and Suicidal Behaviour in Young Adults Across Washington State and Victoria
medical cannabis research: A longitudinal cohort study linked young adult cannabis use with later suicidal behaviour, while also showing that legalization context alone did not explain regional suicide risk patterns. It keeps the evidence readable for…
Cannabis and Violence Risk: What a Large Meta-analysis Really Shows
medical cannabis research: A 63-study meta-analysis found higher odds of violence perpetration and victimization among cannabis users, but the clinical meaning depends heavily on confounding, dose, psychiatric risk, and study design. It keeps the…
Cannabinoids for Back Pain and Migraine: What Randomized Trials Actually Show
medical cannabis research: A systematic review of five randomized trials found cannabinoid effects depend sharply on condition, product type, route, and THC content, with promising migraine and chronic back pain signals but weak class-wide evidence. It…
Cannabinoids for Low Back Pain and Migraine: What Randomized Trials Actually Show
medical cannabis research: A systematic review of five randomized trials found mixed cannabinoid results: promising signals for vaporized THC plus CBD in acute migraine and VER-01 in chronic low back pain, but no class-wide effect. It keeps the evidence…
Pancreatic Cancer Cannabis Trial Finds Modest THC Dose Signals for Anxiety and Sleep
medical cannabis research: CANPAN pilot data suggest personalized medical cannabis may help selected pancreatic cancer patients, with higher THC exposure linked to anxiety and insomnia improvement, but missing data and small numbers limit certainty. It…
